Vobramitamab duocarmazine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vobramitamab duocarmazine, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors [Phase 2]